| Literature DB >> 32311011 |
Meir Shamay1,2, Jennifer A Kanakry1,3, John S W Low4, Netanel A Horowitz5, Guy Journo2, Anuj Ahuja2, Yonatan Eran2, Elinor Barzilai5, Eldad J Dann5,6, Jennifer Stone1, Wan Lu Woo4, Wen-Son Hsieh4, Rena R Xian1,7, Richard F Ambinder1.
Abstract
Epstein-Barr virus (EBV) is associated with a variety of tumors and nonmalignant conditions. Latent EBV genomes in cells, including tumor cells, are often CpG methylated, whereas virion DNA is not CpG methylated. We demonstrate that methyl CpG binding magnetic beads can be used to fractionate among sources of EBV DNA (DNA extracted from laboratory-purified virions vs DNA extracted from latently infected cell lines). We then applied the technique to plasma specimens and showed that this technique can distinguish EBV DNA from patients with EBV-associated tumors (nasopharyngeal carcinoma, Hodgkin lymphoma) and viral DNA from patients without EBV-associated tumors, including immunocompromised patients and patients with EBV(-) Hodgkin lymphoma.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32311011 PMCID: PMC7189298 DOI: 10.1182/bloodadvances.2020001511
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529